AVALO THERAPEUTICS, INC. Deferred Income Tax Assets, Net
AVALO THERAPEUTICS, INC. (AVTX) had Deferred Income Tax Assets, Net of $337.80 thousand as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2020-08-06
- 2020-06-30: Deferred Income Tax Assets, Net $337.80K.
- 2019-12-31: Deferred Income Tax Assets, Net $0.00.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2020-06-30 | $337.80K 10-Q · filed 2020-08-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |